Columbia Research Enhanced Core Premium Income ETF Shares RECI
20.16 USD -0.11 (-0.54%)
At closeNov 10, 2026, 4:10 PM EST
20.16 0.00 0.00%
After hours · Nov 10, 4:10 PM ET
20.16 Day range 20.16
19.98 52-week range 20.70
- YTD
- +0.17%
- 1 year
- +0.17%
News
benzinga.com What's Going On With Apple Stock Monday? Apple (AAPL) outperforms during a market dip, gaining as investors favor mega-cap tech strength. Read the analysis.
benzinga.com What's Going On With Apple Stock Thursday? AAPL holds steady despite market dip. Gene Munster eyes Apple as an underappreciated AI winner as technicals stay bullish.
benzinga.com Apple Is The Most Underappreciated AI Mega-Cap, Analyst Says Apple stock surges nearly 3% today. Explore AAPL price action, AI rotation trends, and EU App Store policy updates.
businesswire.com Recipharm AB: Recipharm creates a global CDMO leader through SEK 1.7
billion strategic acquisitions in the US, Sweden and India STOCKHOLM--(BUSINESS WIRE)--Regulatory News: The first acquisition, comprising US [1] and Swedish [2] operations, is expected to close during the second quarter 2016, after review by the Swedish…
businesswire.com Recipharm AB: Invitation to Presentation of Recipharm’s Interim Report
for the Second Quarter of 2014 on August 14Th STOCKHOLM--(BUSINESS WIRE)--Regulatory News: Recipharm AB (STO:RECI): The company invites investors, analysts and media to a conference call with a web presentation (in English) on August 14 at 10:00…
businesswire.com Recipharm AB: Invitation to Presentation of Recipharm’s Interim Report
for the First Quarter of 2014 on May 8 STOCKHOLM--(BUSINESS WIRE)--Regulatory News: Recipharm (STO:RECI) will publish its interim report for January-March 2014 on May 8 at 07:45 CET. The company invites investors, analysts and media to a…